Thomson Reuters gathers data about investigational drugs to provide developers access to pharmaceutical research. The Thomson Reuters Pharma API allows searching of the company's database. You can filter and rank results, receive briefings about investigational drugs and more. Companies can use the API to create dashboards and competitive intelligence matrices for companies to make sense of the pharmaceutical data.
Open APIs are being adopted by a wide range of industries, even those outside the Internet sector. Most recently the pharmaceutical industry is realizing the benefits of APIs in sharing information around drug research. Thomson Reuters now provides the Thomson Reuters Pharma API for investigational drugs data. The service provides access the company's comprehensive source of global pharmaceutical intelligence on drugs.